short-term treatment of insomnia
Conditions
Interventions
None listed
Sponsors
Orion Corporation
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Outcome results
None listed
Bioequivalence study comparing two temazepam 20 mg tablet formulations after fasted administration; an open, randomized, single centre, single dose study with crossover design in healthy subjects
For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms
Source: EU CTIS · Data processed: May 6, 2026